{
    "code": "72000033",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000033",
    "time": "2023-10-26 19:45:28",
    "許可證字號": "衛部罕菌疫輸字第000033號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "120\/01\/28",
    "發證\/登錄日期": "110\/01\/28",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA07200003306",
    "中文品名": "得釋腫注射劑300毫克",
    "英文品名": "Takhzyro solution for injection",
    "適應症": "適用於12歲以上病人，做為遺傳性血管性水腫(hereditary angioedema，HAE)反覆發作的預防。說明：須符合以下三者之一：1.曾經有過1個月發作3次(含)以上。2.6個月發作達到5次。3.曾有過危及生命之發作。",
    "劑型": "27D注射液劑",
    "包裝": "2mL玻璃小瓶裝，附注射器、穿刺針頭、注射針頭，100支以下盒裝 2 mL預充填玻璃針筒裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分;",
    "監視期限": "115\/01\/28",
    "主成分略述": "lanadelumab",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市信義區松高路1號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "VETTER PHARMA-FERTIGUNG GMBH &amp; CO. KG",
            "製造廠廠址": "SCHUTZENSTRASSE 87 AND 99-101, D-88212 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        },
        {
            "製造廠名稱": "Catalent Indiana LLC",
            "製造廠廠址": "1300 South Patterson Drive, Bloomington, IN 47403, United States",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "TAKEDA MANUFACTURING AUSTRIA AG",
            "製造廠廠址": "Lange Allee 24, 1221, VIENNA, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "RENTSCHLER BIOPHARMA SE",
            "製造廠廠址": "ERWIN-RENTSCHLER-STRAβE 21, 88471 LAUPHEIM, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "DHL SUPPLY CHAIN (NETHERLANDS) B.V",
            "製造廠廠址": "BIJSTERHUIZEN 3142, WIJCHEN, 6604 LV, NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "SHIRE HUMAN GENETIC THERAPIES, INC.",
            "製造廠廠址": "400 SHIRE WAY LEXINGTON, MA 02421, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400008200",
            "成分名稱": "lanadelumab",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "11.1 Takhzyro_PI_EU202007TW02_draft-111-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000033&Seq=003&Type=9"
        },
        {
            "title": "373323_5.2 Takhzyro PFS_carton_0754599_V1_clean-111-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000033&Seq=003&Type=8"
        },
        {
            "title": "373308_5.1 Takhzyro PFS_syringe label_0754597_V1_clean-111-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000033&Seq=002&Type=8"
        },
        {
            "title": "020000330002-110-04-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000033&Seq=001&Type=8"
        }
    ]
}